New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AKR;MCD;MPEL;SYT;RHHBY;TSM;DST;AET;ATHN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
April 14, 2015
11:07 EDTATHNathenahealth volatility elevated into Q1 and outlook
athenahealth April call option implied volatility is at 62, April weekly is at 41, May is at 47, June is at 38; compared to its 26-week average of 38 according to Track Data, suggesting large price movement into the expected release of Q1 results on May 1.
06:30 EDTRHHBYRoche to seek to have cancer drug tested in 11 trials in 2015, Reuters says
Roche said it would seek to have its immunotherapy cancer drug, MPDL3280A, in 11 late stage trials by the end of 2015, aaccording to Reuters. The drug is being tested in melanoma, as well as lung, bladder, kidney, bowel and blood cancers, the news service noted. Reference Link
April 13, 2015
14:42 EDTATHNathenahealth volatility increases into Q1 and outlook
athenahealth April call option implied volatility is at 66, April is at 45, May is at 53, June is at 37; compared to its 26-week average of 38 according to Track Data, suggesting large price movement into the expected release of Q1 results on May 1.
10:58 EDTAETCigna, Humana seen as potential takeover targets in Managed Care space
Subscribe for More Information
10:54 EDTATHNathenahealth deal with Trinity should ease concerns, says Piper Jaffray
Piper Jaffray believes Trinity Health's selection of athenaOne as its EHR, practice management and patient engagement platform will ease concerns over a "dry spell" for athenahealth's enterprise unit. Piper points out athenahealth also announced its latest app, athenaText for Apple Watch, to expand care coordination for providers on its platform. It notes Trinity Health is one of the nation's largest health systems and reiterates an Overweight rating on athenahealth with a $210 price target.
10:50 EDTATHNTrinity Health to implement athenahealth's athenaOne
Subscribe for More Information
10:48 EDTATHNOptions with increasing implied volatility
Options with increasing implied volatility: CLDN WETF EWH FOSL FXI TLM PRGO ATHN SYMC MAC
10:01 EDTRHHBYRoche acquires CAPP Medical
Roche announced it has acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans, to advance the development of technology for cancer screening and monitoring through the detection of circulating tumor DNA in blood.
07:33 EDTAETJefferies sees low probability of WellCare, Centene buyouts
After running several acquisition scenarios for the Managed Care space, Jefferies says potential takeovers of WellCare (WCG) and Centene (CNC) are "hard to justify." The firm estimates acquirers will only be able to generate 1%-3% accretion from buying either company at a 20% premium to current share prices. The deal that makes the most financial sense is Aetna (AET) buying Cigna (CI), Jefferies says today in a note to investors. Also financially attractive would be a buyout of Humana (HUM) by either Anthem (ANTM) or Aetna, the firm adds. After analyzing the Managed Care space, it upgraded this morning shares of UnitedHealth (UNH) to Buy from Hold with a $141 price target. Jefferies also has Buy ratings on Aetna, Anthem, Health Net (HNT) and Molina Healthcare (MOH).
07:31 EDTATHNHealthcare Information & Management Systems Society to hold a conference
HIMSS 2015 is being held in Chicago on April 12-16.
07:29 EDTATHNLeerink to hold booth tours at HIMSS
Subscribe for More Information
April 10, 2015
11:13 EDTATHNLeerink healthcare services analyst holds analyst/industry conference call
Subscribe for More Information
05:54 EDTTSMTSMC to begin Phase 5 construction of Fab 15 facility in May, DigiTimes says
Subscribe for More Information
April 9, 2015
12:27 EDTDSTDST Systems unit to acquire Red Rocks Capital for up to $65M
Subscribe for More Information
April 8, 2015
15:19 EDTRHHBYRoche says receives European approval for Avastin plus chemotherapy
Roche announced that the European Commission approved Avastin -- bevacizumab -- in combination with standard chemotherapy for the treatment of adult patients with persistent, recurrent or metastatic carcinoma of the cervix. The EU approval was based on the significant survival benefit in the pivotal GOG-0240 study, which showed that women who received Avastin plus chemotherapy had a statistically significant 26% reduction in the risk of death, representing a median improvement in survival of nearly four months, compared to women who received chemotherapy alone.
April 7, 2015
14:11 EDTMCDMcDonald's to introduce three new, large burgers, AP says
Subscribe for More Information
12:58 EDTATHNOn The Fly: Midday Wrap
Subscribe for More Information
10:23 EDTAETMedicare Advantage 2016 rates set above expectations
The U.S. yesterday announced higher than expected 2016 Medicare Advantage reimbursement rates. The news is seen as benefiting managed care companies with large exposure to the Medicare Advantage program. WHAT'S NEW: The Centers for Medicare and Medicaid Services, or CMS, yesterday afternoon announced that Medicare Advantage reimbursement rates would rise 1.25% in 2016 from 2015 levels. In February, CMS proposed a 0.95% reduction in Medicare Advantage reimbursement rates for 2016. This year, reimbursement rates have fallen 4%. WHAT'S NOTABLE: Humana (HUM) said this morning in a regulatory filing that based on its review of the Final Rate Notice, the company expects an average Medicare Advantage funding increase for its business of approximately 0.8% from CMS for 2016, versus a funding decline of 1.25%-1.75% previously expected based on the Advance Notice. Humana’s estimated year-over-year funding increase as it affects the company is projected to be less than the CMS estimate for the MA program primarily due to Humana’s view of the projected impact associated with CMS’ 2016 adjustment to the risk model calculation, the company explained. ANALYST REACTION: In a note to investors earlier today, Deutsche Bank analyst Scott Fidel wrote that this is the first time in seven years that CMS has implemented an increase in Medicare Advantage rates. However, noting that CMS said it had raised its estimates for Medicare costs, Fidel added that this forecast tempered the positive outlook created by the reimbursement increase. The analyst kept Buy ratings on the following stocks in the sector: Aetna (AET), Anthem (ANTM), Cigna (CI), Magellan Health (MGLN), and UnitedHealth (UNH). Stifel analysts said that the results were modestly better than expected, except for the agency's decision not to make a Star rating adjustment for plans with certain higher acuity populations. The firm thinks that more diversified managed care companies with Medicare Advantage products could be boosted by CMS' decision, identifying Aetna, Humana, and UnitedHealth as being among the companies in that category. PRICE ACTION: In early trading, Aetna was little changed at $107.40, Anthem was flat near $155 per share, Cigna slipped 0.4% to $131.34, Magellan was flat at $71, UnitedHealth added 0.5% to $118.31 and Humana gained fractionally to $178.54.
10:19 EDTATHNHigh option volume stocks
Subscribe for More Information
10:17 EDTATHNathenahealth April volatility increases on wide price movement
athenahealth April weekly call option implied volatility is at 46, April is at 45, May is at 35, June is at 32; compared to its 26-week average of 38 according to Track Data, suggesting decreasing price movement.
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use